Evidence map›Paper›PMID 26640609›Full record

ArticleTrials in vaccinology

Immunogenicity in dogs and protection against visceral leishmaniasis induced by a 14kDa

Claudia Abeijon, Nada Daifalla, Greice Krautz-Peterson, Stefano Pizzirani, Gillian Beamer, Neuza M Frazatti-Gallina, Isaias Raw, Antonio Campos-Neto

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Trials in vaccinology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Claudia AbeijonDetectoGen Inc. Grafton MA.
Nada DaifallaThe Forsyth Institute, Cambridge MA.
Greice Krautz-PetersonCummings School of Veterinary Medicine at Tufts, Grafton MA.
Stefano PizziraniCummings School of Veterinary Medicine at Tufts, Grafton MA.
Gillian BeamerCummings School of Veterinary Medicine at Tufts, Grafton MA.
Neuza M Frazatti-GallinaBioIndustrial Division, Butantan Institute/Foundation, São Paulo, SP, Brazil.
Isaias RawBioIndustrial Division, Butantan Institute/Foundation, São Paulo, SP, Brazil.
Antonio Campos-NetoDetectoGen Inc. Grafton MA ; The Forsyth Institute, Cambridge MA.
New England Disabled Sports · USInstituto Butantan · BR

Funding

Validation of a new VL vaccine candidate in dogs that significantly protects miceR43AI100327 · NIAID · DETECTOGEN, INC. · PI ABEIJON, CLAUDIA, CAMPOS-NETO, ANTONIO · 2012 to 2013
$600k
Development of a protein-based antigen detection test for kala-azarR43AI113992 · NIAID · DETECTOGEN, INC. · PI ABEIJON, CLAUDIA · 2015 to 2016
$420k
NIAID NIH HHS R43 AI100327NIAID NIH HHS R43 AI113992
6 · The paper itself

Abstract

In areas were human visceral leishmaniasis (VL) is endemic, the domestic dog is the main parasite reservoir in the infectious cycle of

Indexed as

DogLeishmania infantumL. infantum nuclear transport factor 2VaccineVisceral Leishmaniasis

Identifiers

PMID26640609
PMCPMC4667363
OpenAlexW2180762349

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.